Discover how Laverdia CA1 (verdinexor) treats canine lymphoma. Learn about the mechanism of action, handling precautions, and ...
Novo Nordisk said Wednesday that demand for its Wegovy pill got off to a strong start after it launched in the U.S. in early ...
The Chosun Ilbo on MSN
Invossa shareholders lose damages lawsuit
Shareholders who filed a damages lawsuit against developer Kolon TissueGene and others, claiming investment losses due to the ...
If approved by the FDA, the pill could offer an easier alternative than injected cholesterol-lowering medicines.
Asianet Newsable on MSN
Novo Nordisk to launch Ozempic pills following flat growth in diabetes segment in 2025
The Ozempic pill will be launched in Q2 2026 and be available in doses 1.5 mg, 4 mg, and 9 mg.
The FDA issued a recall Wednesday for a honey energy supplement after an undeclared erectile dysfunction medication was found ...
Twenty-two percent of U.S. doctors prescribing initial treatment for children with a new diagnosis of anxiety or depression ...
Johnson & Johnson’s Abiomed has sent an urgent medical device correction about a malfunction risk linked to 22 reports of ...
The Trump administration has made cutting drug costs a key priority, and drugmakers are responding with lower prices.
A milestone in the treatment of Duchenne muscular dystrophy (DMD) passed recently with remarkably little public notice. That ...
Half of the planned 200 ALS patients have joined Medicinova’s expanded access program evaluating the experimental drug MN-166.
The U.S. FDA has granted fast track status to pelareorep combination therapy for some KRAS-mutant, microsatellite-stable metastatic colorectal cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results